Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study.

"Disclosures Dr Mathews discloses speaker’s bureau from Philips, Penumbra, Boston Scientific, Shockwave, Cordis, and Cardiva; grant or research support from Philips, Abbott Vascular, Reflow Medical, Boston Scientific, Trireme, and Penumbra; service as a consultant for Penumbra; and service on medical or scientific boards for Boston Scientific, Philips, Angiodynamics, Abbott Vascular, Evident Vascular, Reflow Medical, Akura Medical, and Innova. Dr Parikh discloses research support from Abbott, Boston Scientific, Shockwave, TriReme, and Surmodics; service on the advisory board for Abbott, Boston Scientific, Medtronic, Janssen, Philips, and Cordis; and service as a consultant for Abiomed, Penumbra, Inari, Canon, and Terumo. Dr Metzger discloses Speaker’s honoraria from Penumbra. Dr Chamber discloses service as the CMO for Cardiovascular Systems, Inc, and as a consultant for Boston Scientific, Philips, and Teleflex. Dr Ghali discloses service as a speaker for Penumbra (invited after CHEETAH study completion). Dr Kolski discloses research and grant support for clinical research from Providence St Joseph and service as a speaker and consultant for Penumbra. Dr Pinto discloses service as a consultant for Abbott Vascular, Abiomed, Boston Scientific, Inari, Philips, Terumo, Teleflex, Biotronik, Medtronic, NuPulseCV, and Magenta. Dr Dohad reports institutional research and grant support for clinical research and fellowship training from Penumbra, and service as a speaker and consultant for Penumbra. The other authors report no conflicts."

"Sources of Funding This study was funded by Penumbra Inc (Alameda, CA)."

"Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03957473."